One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Inequality and health: all is not equal
doi : 10.1016/S2665-9913(24)00380-1
Jan 2025 Volume 7Number 1e1-e72
Susac syndrome: challenges of interpreting treatment data in a rare disease
Targeting sphingosine-1-phosphate receptor modulator in SLE: a promising new therapeutic option
Structural racism is a driver of fragmented care and acute care use among people with rheumatic conditions
Substantiation of trophoblast transport of maternal anti-SSA/Ro autoantibodies in fetuses with rapidly progressive cardiac injury: implications for neonatal Fc receptor blockade
Dermatology response to the Hyperinflammation and HLH Across Specialty Collaboration consensus guideline
Dermatology response to the Hyperinflammation and HLH Across Specialty Collaboration consensus guideline – Authors' reply
Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
Association of historical redlining and present-day racialised economic segregation with health-care utilisation among individuals with rheumatic conditions in Massachusetts and surrounding areas of the USA: a retrospective cohort study
Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study
Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritis
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework
